Latest stories on AAPG
Ascentage Pharma to Participate in Four Upcoming Investor Conferences
GlobeNewswire55 · neutralgeneral
Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Ascentage Pharma Group International H1 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
Ascentage Pharma Group International 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Ascentage Pharma Group International GAAP EPS of -$0.32 beats by $0.23, revenue of $44.5M misses by $7.73M
Seeking Alpha56 · neutralearnings
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
GlobeNewswire63 · neutralearnings
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
Business Insider63 · neutralearnings
Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast
TipRanks50 · neutralgeneral
Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
StockTitan55 · neutralgeneral
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Business Insider50 · neutralgeneral
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Business Insider50 · neutralgeneral
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
Business Insider50 · neutralgeneral
Ascentage Pharma CEO Dajun Yang Ranked Among Top Small-Molecule Leaders in 2026 Power List
TipRanks55 · neutralgeneral
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
StockTitan50 · neutralgeneral
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
Business Insider50 · neutralgeneral
Ascentage Pharma Sets Up US$200 Million Nasdaq ATM Offering Following SEC Shelf Filing
TipRanks24 · bearishgeneral
Ascentage Pharma Corrects AGM Date Underpinning Equity Incentive Mandate
TipRanks50 · neutralgeneral
Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development
Yahoo Top67 · bullishanalyst
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress | AAPG Stock News
StockTitan73 · bullishproduct/pr
Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib Data
Yahoo Top67 · bullishproduct/pr
Ascentage Pharma Showcases First Pediatric Alrizomadlin Data at ASCO 2026
TipRanks67 · bullishproduct/pr
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026 | AAPG Stock News
StockTitan67 · bullishproduct/pr
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026 | AAPG Stock News
StockTitan63 · neutralproduct/pr